United Kingdom · Question · Written question
UIN 691
Tixagevimab/cilgavimab
Original
Introduced
11 May 2022
Last action
21 June 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
21 June 2022
Summary
To ask the Secretary of State for Health and Social Care, what timeframe UKHSA are working to in order to assess the effectiveness of Evusheld against the Omicron variant of covid-19.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 May 2022
Written question
To ask the Secretary of State for Health and Social Care, what timeframe UKHSA are working to in order to assess the effectiveness of Evusheld against the Omicron variant of covid-19.
Source: Commons
21 June 2022
Answer
The UK Health Security Agency continues to undertake further testing on Evusheld’s effectiveness against the Omicron variants. However, we are currently unable to confirm a timeframe for this process.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-05-11/691
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1462003
- uk · wq-1462003 · source updated 21 June 2022